[ Price : $8.95]
FDA publishes a draft guidance with recommendations for NDA and ANDA applicants for nonprescription drugs to document minor labeli...[ Price : $8.95]
CVM warns Boehringer Ingelheim Animal Health USA that promotional communications for its Senvelgo make false and misleading claims...[ Price : $8.95]
FDA publishes a draft guidance proposing select updates to its existing premarket cybersecurity guidance.[ Price : $8.95]
A Duke-Margolis Institute for Health Policy report on an FDA-funded virtual workshop on drug digital marketing identifies several ...[ Price : $8.95]
FDA and Instem researchers say 92% of Medical Device Reports filed between 2011 and 2021 involved device issues rather than patien...[ Price : $8.95]
Pfizer plans to share with FDA favorable data from its Phase 3 study of the antibody-drug conjugate Adcetris (brentuximab vedotin)...[ Price : $8.95]
Lexicon Pharmaceuticals says that after receiving recent FDA feedback it plans to resubmit its NDA for sotagliflozin oral tablets ...[ Price : $8.95]
Acadia Pharmaceuticals stops developing pimavanserin for treating negative symptoms of schizophrenia based on disappointing top-li...